Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Irritable Bowel Syndrome

Free Subscription Articles published in Gastroenterology Retrieve available abstracts of 64 articles: HTML format

Single Articles

March 2024
1. KHASAWNEH M, Black CJ, Ford AC
   Efficacy of Drugs Acting on Histamine-1 Receptors in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
   Gastroenterology. 2024 Mar 16:S0016-5085(24)00297.
   PubMed    
   
   
   
2. ZINGONE F, Bai JC, Cellier C, Ludvigsson JF, et al
   Celiac disease-related conditions: Who to test?
   Gastroenterology. 2024 Mar 7:S0016-5085(24)00282.
   PubMed     Abstract available
   
   
   
3. PEERY AF, Kelly CR, Kao D, Vaughn BP, et al
   AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
   Gastroenterology. 2024;166:409-434.
   PubMed     Abstract available
   
   
   February 2024
4. VAN DEN HOUTE K, Colomier E, Routhiaux K, Marien Z, et al
   Efficacy and findings of a blinded randomized reintroduction phase for the low FODMAP diet in Irritable Bowel Syndrome.
   Gastroenterology. 2024 Feb 22:S0016-5085(24)00170.
   PubMed     Abstract available
   
   
   
5. FORD AC, Vanner S, Kashyap PC, Nasser Y, et al
   CHRONIC VISCERAL PAIN: NEW PERIPHERAL MECHANISTIC INSIGHTS AND RESULTING TREATMENTS.
   Gastroenterology. 2024 Feb 5:S0016-5085(24)00132.
   PubMed     Abstract available
   
   
   
6. TACK J, Carbone F, Chang L, Lacy BE, et al
   Patient reported outcomes in Disorders of Gut-Brain Interaction.
   Gastroenterology. 2024 Feb 1:S0016-5085(24)00124.
   PubMed     Abstract available
   
   
   December 2023
7. SHIHA MG, Aziz I
   Amitriptyline for the management of IBS in primary care.
   Gastroenterology. 2023 Dec 24:S0016-5085(23)05680.
   PubMed     Abstract available
   
   
   
8. SO SY, Badu S, Wu Q, Yalcinkaya N, et al
   Sex-dependent efficacy of dietary fiber in pediatric functional abdominal pain.
   Gastroenterology. 2023 Dec 18:S0016-5085(23)05607.
   PubMed     Abstract available
   
   
   
9. SEHGAL K, Yadav D, Saha S, Mara K, et al
   Sex-Discordant Fecal Microbiota Transplantation for C. difficile may increase risk of post-infection irritable bowel syndrome.
   Gastroenterology. 2023 Dec 4:S0016-5085(23)05570.
   PubMed    
   
   
   November 2023
10. GARG P, Garg PK, Bhattacharya K
    Psyllium husk positively alters gut microbiota, decreases inflammation and has bowel-regulatory action, paving way for physiological management of irritable bowel syndrome (IBS).
    Gastroenterology. 2023 Nov 16:S0016-5085(23)05241.
    PubMed    
    
    
    August 2023
11. ALMARIO CV, Sharabi E, Chey WD, Lauzon M, et al
    Prevalence and Burden of Illness of Rome IV Irritable Bowel Syndrome in the United States: Results from a Nationwide Cross-Sectional Study.
    Gastroenterology. 2023 Aug 16:S0016-5085(23)04889.
    PubMed     Abstract available
    
    
    
12. GOODOORY VC, Khasawneh M, Black CJ, Quigley EM, et al
    Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
    Gastroenterology. 2023 Aug 2:S0016-5085(23)04838.
    PubMed     Abstract available
    
    
    June 2023
13. BALLOU S, Singh P, Nee J, Rangan V, et al
    Prevalence and Associated Factors of Bloating: Results from the Rome Foundation Global Epidemiology Study.
    Gastroenterology. 2023 Jun 12:S0016-5085(23)00826.
    PubMed     Abstract available
    
    
    
14. HREINSSON JP, Tornblom H, Tack J, Drossman DA, et al
    Factor Analysis of the Rome IV Criteria for Major Disorders of Gut-Brain Interaction (DGBI) Globally and Across Geographical, Sex, and Age Groups.
    Gastroenterology. 2023;164:1211-1222.
    PubMed     Abstract available
    
    
    February 2023
15. FOGELSON KA, Dorrestein PC, Zarrinpar A, Knight R, et al
    The Gut Microbial Bile Acid Modulation and its Relevance to Digestive Health and Diseases.
    Gastroenterology. 2023 Feb 23:S0016-5085(23)00161.
    PubMed     Abstract available
    
    
    January 2023
16. ZHOU Q, Yang L, Verne ML, Zhang BB, et al
    Catechol-O-Methyltransferase Loss Drives Cell-Specific Nociceptive Signaling via the Enteric COMT/miR-155/TNF-alpha Axis.
    Gastroenterology. 2023 Jan 6:S0016-5085(23)00008.
    PubMed     Abstract available
    
    
    October 2022
17. CAMILLERI M, Dilmaghani S
    Treatment of Irritable Bowel Syndrome Using Fecal Microbiota Transplantation: A Step Forward?
    Gastroenterology. 2022;163:815-817.
    PubMed    
    
    
    September 2022
18. KESZTHELYI D
    Histamine-producing bacteria: the missing link in irritable bowel syndrome?
    Gastroenterology. 2022 Sep 8. pii: S0016-5085(22)01038.
    PubMed    
    
    
    August 2022
19. GRABAUSKAS G, Gao J, Wu X, Zhou SY, et al
    Gut Microbiota Alter Visceral Pain Sensation and Inflammation via Modulation of Synthesis of Resolvin D1 in Colonic Tuft Cells.
    Gastroenterology. 2022 Aug 4. pii: S0016-5085(22)00829.
    PubMed     Abstract available
    
    
    July 2022
20. LEMBO A, Sultan S, Chang L, Heidelbaugh JJ, et al
    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea.
    Gastroenterology. 2022;163:137-151.
    PubMed     Abstract available
    
    
    
21. CHANG L, Sultan S, Lembo A, Verne GN, et al
    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.
    Gastroenterology. 2022;163:118-136.
    PubMed     Abstract available
    
    
    June 2022
22. ZIA JK, Lenhart A, Yang PL, Heitkemper MM, et al
    Risk Factors for Abdominal Pain Disorders of Gut Brain Interaction in Adults and Children: A Systematic Review.
    Gastroenterology. 2022 Jun 15. pii: S0016-5085(22)00646.
    PubMed     Abstract available
    
    
    
23. EL-SALHY M, Winkel R, Casen C, Hausken T, et al
    Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at three years after transplantation.
    Gastroenterology. 2022 Jun 13. pii: S0016-5085(22)00625.
    PubMed     Abstract available
    
    
    April 2022
24. BUSHYHEAD D, Quigley EMM
    Small Intestinal Bacterial Overgrowth, Pathophysiology and its implications for Definition and Management.
    Gastroenterology. 2022 Apr 7. pii: S0016-5085(22)00357.
    PubMed     Abstract available
    
    
    
25. AHUJA A
    Minority Patients With Irritable Bowel Syndrome Receive More Gastroenterology-Related Procedures Than White Counterparts: Nuances in Disparities Research.
    Gastroenterology. 2022;162:1354-1355.
    PubMed    
    
    
    March 2022
26. CHEY WD, Hashash JG, Manning L, Chang L, et al
    AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.
    Gastroenterology. 2022 Mar 22. pii: S0016-5085(21)04084.
    PubMed     Abstract available
    
    
    February 2022
27. GAO J, Xiong T, Grabauskas G, Owyang C, et al
    Mucosal serotonin reuptake transporter (SERT) expression in IBS is modulated by gut microbiota via mast cell-prostaglandin E2.
    Gastroenterology. 2022 Feb 12. pii: S0016-5085(22)00144.
    PubMed     Abstract available
    
    
    January 2022
28. BLACK CJ, Ford AC
    Assessing the Impact of Changes to the Rome IV Criteria for Clinical Practice in Irritable Bowel Syndrome.
    Gastroenterology. 2022 Jan 22. pii: S0016-5085(22)00037.
    PubMed    
    
    
    December 2021
29. DEB B, Sharma M, Fletcher JG, Srinivasan SG, et al
    Inadequate Rectal Pressure and Insufficient Relaxation and Abdominopelvic Coordination in Defecatory Disorders.
    Gastroenterology. 2021 Dec 21. pii: S0016-5085(21)04093.
    PubMed     Abstract available
    
    
    
30. MAGNUS Y, BouSaba J, Sannaa W, McKinzie S, et al
    Bile Acid Diarrhea Is Associated with Increased Intestinal Permeability Compared to Irritable Bowel Syndrome-Diarrhea.
    Gastroenterology. 2021 Dec 16. pii: S0016-5085(21)04078.
    PubMed    
    
    
    November 2021
31. ZHENG T, Camargo-Tavares L, Bonfiglio F, Marques FZ, et al
    Rare Hypomorphic Sucrase Isomaltase Variants in Relation to Irritable Bowel Syndrome Risk in UK Biobank.
    Gastroenterology. 2021;161:1712-1714.
    PubMed    
    
    
    October 2021
32. CHANG L
    How to Approach a Patient with Difficult-to-Treat IBS.
    Gastroenterology. 2021;161:1092-1098.
    PubMed    
    
    
    September 2021
33. KEEFER L, Ballou SK, Drossman DA, Ringstrom G, et al
    A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03494.
    PubMed     Abstract available
    
    
    
34. CAMILLERI M
    New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders.
    Gastroenterology. 2021;161:761-764.
    PubMed    
    
    
    July 2021
35. MIHINDUKULASURIYA KA, Mars RAT, Johnson AJ, Ward T, et al
    Multi-omics analyses show disease, diet, and transcriptome interactions with the virome.
    Gastroenterology. 2021 Jul 7. pii: S0016-5085(21)03234.
    PubMed     Abstract available
    
    
    June 2021
36. REINISCH W
    PEG and mucosal biofilms in irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03167.
    PubMed    
    
    
    
37. BAUMGARTNER M, Lang M, Holley H, Crepaz D, et al
    Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 16. pii: S0016-5085(21)03138.
    PubMed     Abstract available
    
    
    April 2021
38. KHOSHBIN K, Khanna L, Maselli D, Atieh J, et al
    Development and Validation of Test for "Leaky Gut" Small Intestinal and Colonic Permeability Using Sugars in Healthy Adults.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00642.
    PubMed     Abstract available
    
    
    March 2021
39. HASAN SS, Whorwell PJ, Miller V, Morris J, et al
    Six versus twelve sessions of gut-focused hypnotherapy for irritable bowel syndrome: a randomized trial.
    Gastroenterology. 2021 Mar 1. pii: S0016-5085(21)00463.
    PubMed    
    
    
    February 2021
40. MAHURKAR-JOSHI S, Rankin CR, Videlock EJ, Soroosh A, et al
    The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p and MicroRNA-338-3p, are Downregulated in Irritable Bowel Syndrome and are Associated with Barrier Function and MAPK signaling.
    Gastroenterology. 2021 Feb 19. pii: S0016-5085(21)00430.
    PubMed     Abstract available
    
    
    January 2021
41. MARGOLIS KG, Cryan JF, Mayer EA
    The Microbiota-Gut-Brain Axis: From Motility to Mood.
    Gastroenterology. 2021 Jan 22. pii: S0016-5085(21)00268.
    PubMed     Abstract available
    
    
    
42. MARS RAT, Frith M, Kashyap PC
    Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?
    Gastroenterology. 2021;160:538-555.
    PubMed     Abstract available
    
    
    
43. O'TOOLE PW, Shanahan F
    Transplanting Microbes for Irritable Bowels or Irritated Microbes or Both?
    Gastroenterology. 2021;160:15-17.
    PubMed    
    
    
    October 2020
44. CHEY WD, Keefer L, Whelan K, Gibson PR, et al
    Behavioral and Diet Therapies in Integrated Care for Patients with Irritable Bowel Syndrome.
    Gastroenterology. 2020 Oct 19. pii: S0016-5085(20)35281.
    PubMed     Abstract available
    
    
    September 2020
45. MA C, Congly SE, Novak KL, Belletrutti PJ, et al
    Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35224.
    PubMed     Abstract available
    
    
    
46. KELLY CR, Yen EF, Grinspan AM, Kahn SA, et al
    Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35221.
    PubMed     Abstract available
    
    
    July 2020
47. HOLVOET T, Joossens M, Vazquez-Castellanos JF, Christiaens E, et al
    Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome with Predominant Abdominal Bloating: Short- and Long-Term Results from a Placebo-Controlled Randomized Trial.
    Gastroenterology. 2020 Jul 15. pii: S0016-5085(20)34937.
    PubMed     Abstract available
    
    
    
48. QUIGLEY EM, Murray JA, Pimentel M
    AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review.
    Gastroenterology. 2020 Jul 14. pii: S0016-5085(20)34928.
    PubMed     Abstract available
    
    
    
49. WEERTS ZZRM, Masclee AAM, Jonkers DMAE, Keszthelyi D, et al
    Reply.
    Gastroenterology. 2020;159:396-397.
    PubMed    
    
    
    
50. UNO Y
    Why a Low FODMAP Diet Was Ineffective for IBS Symptoms in Quiescent Crohn's Disease.
    Gastroenterology. 2020;159:399.
    PubMed    
    
    
    
51. MULLIN GE, Chey WD, Crowe SE
    The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease.
    Gastroenterology. 2020;159:20-25.
    PubMed    
    
    
    April 2020
52. SPERBER AD, Bangdiwala SI, Drossman DA, Ghoshal UC, et al
    Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study.
    Gastroenterology. 2020 Apr 12. pii: S0016-5085(20)30487.
    PubMed     Abstract available
    
    
    
53. BLACK CJ, Moayyedi P, Quigley EM, Ford AC, et al
    Peppermint Oil in Irritable Bowel Syndrome.
    Gastroenterology. 2020 Apr 11. pii: S0016-5085(20)30478.
    PubMed    
    
    
    
54. ZHOU Q, Verne GN
    Are the Rome Criteria a Sound Standard for Gastrointestinal Disorders Worldwide?
    Gastroenterology. 2020;158:1212-1214.
    PubMed    
    
    
    February 2020
55. GRABAUSKAS G, Wu X, Gao J, Li JY, et al
    Prostaglandin E2, Produced by Mast Cells in Colon Tissues from Patients with Irritable Bowel Syndrome, Contributes to Visceral Hypersensitivity in Mice.
    Gastroenterology. 2020 Feb 18. pii: S0016-5085(20)30232.
    PubMed     Abstract available
    
    
    
56. BLACK CJ, Ford AC
    Predicting response to rifaximin in irritable bowel syndrome with diarrhea: Is the answer blowing in the wind?
    Gastroenterology. 2020 Feb 14. pii: S0016-5085(20)30227.
    PubMed     Abstract available
    
    
    January 2020
57. PALSSON OS, Whitehead W, Tornblom H, Sperber AD, et al
    Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Gastroenterology. 2020 Jan 6. pii: S0016-5085(20)30001.
    PubMed     Abstract available
    
    
    December 2019
58. DELSHAD SD, Almario CV, Chey WD, Spiegel BMR, et al
    Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms.
    Gastroenterology. 2019 Dec 18. pii: S0016-5085(19)41941.
    PubMed     Abstract available
    
    
    
59. JEFFERY IB, Das A, O'Herlihy E, Coughlan S, et al
    Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Gastroenterology. 2019 Dec 13. pii: S0016-5085(19)41920.
    PubMed     Abstract available
    
    
    November 2019
60. CASH BD
    A Minty Breath of Fresh Air for Irritable Bowel Syndrome.
    Gastroenterology. 2019 Nov 12. pii: S0016-5085(19)41534.
    PubMed    
    
    
    
61. KAMPHUIS JBJ, Guiard B, Leveque M, Olier M, et al
    Lactose and Fructo-oligosaccharides Increase Visceral Sensitivity in Mice via Glycation Processes, Increasing Mast Cell Density in Colonic Mucosa.
    Gastroenterology. 2019 Nov 8. pii: S0016-5085(19)41528.
    PubMed     Abstract available
    
    
    
62. RANGAN V, Ballou S, Shin A, Camilleri M, et al
    Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction, Based on IBS in America Survey.
    Gastroenterology. 2019 Nov 8. pii: S0016-5085(19)41527.
    PubMed    
    
    
    October 2019
63. SHAPIRO J, El-Serag HB, Chan J
    DURABILITY AND EFFECTIVENESS OF COGNITIVE BEHAVIORAL THERAPY FOR IRRITABLE BOWEL SYNDROME.
    Gastroenterology. 2019 Oct 12. pii: S0016-5085(19)41447.
    PubMed    
    
    
    September 2019
64. COX SR, Lindsay JO, Fromentin S, Stagg AJ, et al
    Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Gastroenterology. 2019 Sep 27. pii: S0016-5085(19)41366.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.